Patient Guide: Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 249 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT03867084
Status: ACTIVE_NOT_RECRUITING
Condition: Hepatocellular Carcinoma
Phase: PHASE3

Find a Study Location Near You

This study is available at 249 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Gilbert, Arizona
  • Tucson, Arizona
  • Duarte, California
  • • And 246 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily